Fuzhou Luyan Pharmaceutical Co., Ltd. announced that it will receive CNY 69,920,000 in an equity round of funding from returning investor Luyan Pharma Co.,Ltd. on October 27, 2021. Post closing, the registered capital of the company will increase from CNY 30,080,000 to CNY 100,000,000, and the investor will continue to indirectly hold 100% stake in the company. The transaction has been approved in the seventh meeting of the fifth board of directors of the investor, and is not subject to its shareholders' approval.